IBDEI0LO ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10105,2)
 ;;=^5002673
 ;;^UTILITY(U,$J,358.3,10106,0)
 ;;=E09.339^^44^500^32
 ;;^UTILITY(U,$J,358.3,10106,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10106,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10106,1,4,0)
 ;;=4^E09.339
 ;;^UTILITY(U,$J,358.3,10106,2)
 ;;=^5002557
 ;;^UTILITY(U,$J,358.3,10107,0)
 ;;=E09.349^^44^500^36
 ;;^UTILITY(U,$J,358.3,10107,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10107,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10107,1,4,0)
 ;;=4^E09.349
 ;;^UTILITY(U,$J,358.3,10107,2)
 ;;=^5002559
 ;;^UTILITY(U,$J,358.3,10108,0)
 ;;=E13.319^^44^500^50
 ;;^UTILITY(U,$J,358.3,10108,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10108,1,3,0)
 ;;=3^Diab w/ Unspec Diabetic Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10108,1,4,0)
 ;;=4^E13.319
 ;;^UTILITY(U,$J,358.3,10108,2)
 ;;=^5002674
 ;;^UTILITY(U,$J,358.3,10109,0)
 ;;=H52.4^^44^501^57
 ;;^UTILITY(U,$J,358.3,10109,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10109,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,10109,1,4,0)
 ;;=4^H52.4
 ;;^UTILITY(U,$J,358.3,10109,2)
 ;;=^98095
 ;;^UTILITY(U,$J,358.3,10110,0)
 ;;=H01.004^^44^501^6
 ;;^UTILITY(U,$J,358.3,10110,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10110,1,3,0)
 ;;=3^Blepharitis,Left Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,10110,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,10110,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,10111,0)
 ;;=H01.005^^44^501^5
 ;;^UTILITY(U,$J,358.3,10111,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10111,1,3,0)
 ;;=3^Blepharitis,Left Lower Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,10111,1,4,0)
 ;;=4^H01.005
 ;;^UTILITY(U,$J,358.3,10111,2)
 ;;=^5133380
 ;;^UTILITY(U,$J,358.3,10112,0)
 ;;=H02.105^^44^501^24
 ;;^UTILITY(U,$J,358.3,10112,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10112,1,3,0)
 ;;=3^Ectropion,Left Lower Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,10112,1,4,0)
 ;;=4^H02.105
 ;;^UTILITY(U,$J,358.3,10112,2)
 ;;=^5133409
 ;;^UTILITY(U,$J,358.3,10113,0)
 ;;=H02.104^^44^501^25
 ;;^UTILITY(U,$J,358.3,10113,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10113,1,3,0)
 ;;=3^Ectropion,Left Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,10113,1,4,0)
 ;;=4^H02.104
 ;;^UTILITY(U,$J,358.3,10113,2)
 ;;=^5004305
 ;;^UTILITY(U,$J,358.3,10114,0)
 ;;=H02.101^^44^501^27
 ;;^UTILITY(U,$J,358.3,10114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10114,1,3,0)
 ;;=3^Ectropion,Right Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,10114,1,4,0)
 ;;=4^H02.101
 ;;^UTILITY(U,$J,358.3,10114,2)
 ;;=^5004303
 ;;^UTILITY(U,$J,358.3,10115,0)
 ;;=H02.102^^44^501^26
 ;;^UTILITY(U,$J,358.3,10115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10115,1,3,0)
 ;;=3^Ectropion,Right Lower Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,10115,1,4,0)
 ;;=4^H02.102
 ;;^UTILITY(U,$J,358.3,10115,2)
 ;;=^5133407
 ;;^UTILITY(U,$J,358.3,10116,0)
 ;;=H04.121^^44^501^23
 ;;^UTILITY(U,$J,358.3,10116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10116,1,3,0)
 ;;=3^Dry Eye Syndrome,Right Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,10116,1,4,0)
 ;;=4^H04.121
 ;;^UTILITY(U,$J,358.3,10116,2)
 ;;=^5004463
 ;;^UTILITY(U,$J,358.3,10117,0)
 ;;=H04.122^^44^501^22
 ;;^UTILITY(U,$J,358.3,10117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10117,1,3,0)
 ;;=3^Dry Eye Syndrome,Left Lacrimal Gland
 ;;^UTILITY(U,$J,358.3,10117,1,4,0)
 ;;=4^H04.122
 ;;^UTILITY(U,$J,358.3,10117,2)
 ;;=^5004464
 ;;^UTILITY(U,$J,358.3,10118,0)
 ;;=H43.811^^44^501^80
 ;;^UTILITY(U,$J,358.3,10118,1,0)
 ;;=^358.31IA^4^2
